Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review

References

• Abdel-Rahman A, Shetty AK, Abou-Donia MB. 2002. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose–response relationships. Neuroscience. 113: 721–741.
   PubMed Web of Science ®Google Scholar
• Abe O, Yamasue H, Kasai K, Yamada H, Aoki S, Iwanami A, Ohtani T, Masutani Y, Kato N, Ohtomo K. 2006. Voxel-based diffusion tensor analysis reveals aberrant anterior cingulum integrity in posttraumatic stress disorder due to terrorism. Psychiatry Res. 146: 231–242.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB, Abdel-Rahman AA, Olin IK, Jensen KF, Wilmarth HR. 1997. A single exposure to sarin increases neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and permethrin. Toxicologist. 36:346.
   Google Scholar
• Abou-Donia MB, Dechkovskaia AM, Goldstein LB, Bullman SL, Khan WA. 2002. Sensorimotor deficit and cholinergic changes following co-exposure with pyridostigmine bromide (PB) and sarin in rats. Toxicol Sci. 66:148–158.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB, Lapadula D. 1990. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Annu Rev Pharmacol Toxicol. 30:405–440.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB, Viana ME, Gupta RP, Knoth-Anderson J. 1993. Enhanced calmodulin binding concurrent with increased kinase-dependent phosphorylation of cytoskeletal proteins following a single subcutaneous injection of diisopropyl phosphorofluoridate (DFP) in hens. Neurochem Int. 22:165–173.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB. 2015. Pesticides. In: Abou-Donia MB, editor. Mammalian toxicology. UK: John Wiley & Sons. p. 131–167.
   Google Scholar
• Abou-Donia MB. 1981. Organophosphorus ester-induced delayed neurotoxicity. Annu Rev Pharmacol Toxicol. 21:511–548.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB. 1993. The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity. Chem Biol Interact. 87:383–393.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB. 1995. Involvement of cytoskeletal proteins in the mechanisms of organophosphorus ester-induced delayed neurotoxicity. Clin Exp Pharmacol Physiol. 22:358–359.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB. 2003. Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health. 58:484–497.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB, Abdel-Rahman AA, Goldstein DU, Bullman SL, Khan WA. 2004. Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats. Arch Toxicol. 77:452–458.
   Web of Science ®Google Scholar
• Abou-Donia MB, Salama M, Abdel-Rahman A. 2016. Propetamphos enhances chlorpyrifos-induced organophosphate-induced delayed neurotoxicity (OPIDN) in hens: a role for plasma butyrylcholinesterase. Toxicol Environ Chem. 98:924–941.
   Web of Science ®Google Scholar
• Abraham BR, Rudick V, Weinbroum AA. 2002. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication. Anesthesiology. 297:989–1004.
   Web of Science ®Google Scholar
• Abu-Qare AW, Abou-Donia MB. 2001a. Combined exposure to sarin and pyridostigmine bromide increased levels of 3-nitrotyrosine and 8-hydroxy-2′-deoxyguanosine, biomarkers of oxidative stress in rat urine. Toxicol Lett. 123:51–58.
   PubMed Web of Science ®Google Scholar
• Abu-Qare AW, Abou-Donia MB. 2001b. Biomarkers of apoptosis: Release of cytochrome c, induction of 8-hydroxy-2′-deoxygunosine, increased of 3-nitrotyrosine, activation of caspase-3, and alteration of P53 gene. Toxicol. Environ. Health Part B. 4:313–332.
   PubMed Web of Science ®Google Scholar
• Abu-Qare AW, Abou-Donia MB. 2002. Sarin: health effects, metabolism, and methods of analysis. Food Chem Toxicol. 40:1327–1333.
   PubMed Web of Science ®Google Scholar
• Abu-Qare AW, Abou-Donia MB. 2008. In vitro metabolism and interaction of pyridostigmine bromide, N,N-diethyl-m-toluamide, and permethrin in human plasma and liver microsomal enzymes. Xenobiotica. 38:294–313.
   PubMed Web of Science ®Google Scholar
• Acharya J, Dubey DK, Srivastava AK, Raza SK. 2010. In vitro reactivation of sarin-inhibited human cetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers. Toxicol In Vitro. 25:251–256.
   PubMed Web of Science ®Google Scholar
• Aldridge WN. 1954. Tricresylphosphates and cholinesterase. Biochem J. 56:185–189.
   PubMed Web of Science ®Google Scholar
• Aldridge WN, Barnes JM. 1966. Further observations on the neurotoxicity of organophosphorus compounds. Biochem Pharmacol. 15:541–547.
   PubMed Web of Science ®Google Scholar
• Allon N, Chapman S, Egox I, Rabinovitz I, Kapon J, Weissman BA, Yacov G, Bloch-Shilderman E, Grauer E. 2011. Deterioration in brain and heart function following a single sub-lethal (0.8 LCt50) inhalation exposure of rates to sarin vapor: a putative mechanism of the long term toxicity. Toxicol Appl Pharmacol. 253:31–37.
   PubMed Web of Science ®Google Scholar
• Araki T, Kasai K, Yamasue H, Kato N, Kudo N, Ohtani T, Nakagome K, Kirihara K, Yamada H, Abe O, Iwanami A. 2005. Association between lower P300 amplitude and smaller anterior cingulate cortex volume in patients with posttraumatic stress disorder: a study of victims of Tokyo subway sarin attack. Neuroimage. 25:43–50.
   PubMed Web of Science ®Google Scholar
• Ashani Y, Shapira S, Levy D, Wolfe AD, Raveh L. 1991. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem Pharmacol. 41:37–41.
   PubMed Web of Science ®Google Scholar
• Austin L, Davies DR. 1954. The part played by inhibition of cholinesterases of the CNS in producing paralysis in chickens. Br J Pharmacol Chemother. 9:145–152.
   PubMed Web of Science ®Google Scholar
• Banks CN, Lein PJ. 2012. A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology. 33:575–584.
   PubMed Web of Science ®Google Scholar
• Ben Abraham R, Rudick V, Weinbroum AA. 2002. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication. Anesthesiology. 97:989–1004.
   PubMed Web of Science ®Google Scholar
• Black KJ. 1995. The ABCs of neuropsychiatry. J Neuropsychiatry Clin Neurosci. 7:273.
   PubMed Web of Science ®Google Scholar
• Blick DW, Kerenyi SZ, Miller S, Murphy MR, Brown GC, Hartgraves. 1991. Behavioral toxicity of anticholinesterases in primates: chronic pyridostigmine and soman interactions. Pharmacol Biochem Behav. 38:527–532.
   PubMed Web of Science ®Google Scholar
• Block H, Hottinger A. 1943. Uber die Spezifitai der Cholinesterase-Hemmung durch tr-krezyl phosphat. Z Vitaminforsch. 13:90.
   Google Scholar
• Brimblecombe RW, Green DM, Stratton JA, Thompson PBJ. 1970. The protective actions of some anticholinergic drugs in sarin poisoning. Br J Pharmacol. 39:822–830.
   PubMed Web of Science ®Google Scholar
• Brimijoin S. 2005. Can cholinesterase inhibitors affect neural development? Environ Toxicol Pharmacol. 19:429–432.
   PubMed Web of Science ®Google Scholar
• Brown MA, Brix KA. 1998. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J Appl Toxicol. 18:393–408.
   PubMed Web of Science ®Google Scholar
• Bucci TJ, Kovatch RM, Mercieca MD, Perman V, Klingensmith JS. 2003. Two-generation reproductive study in mink fed diisopropyl methylphosphonate (DIMP). Reprod Toxicol. 17:327–334.
   PubMed Web of Science ®Google Scholar
• Burchfiel JL, Duffy FH, Van Sim M. 1976. Persistent effects of sarin and dieldrin upon the primate electroencephalogram. Toxicol Appl Pharmacol. 35:365–379.
   PubMed Web of Science ®Google Scholar
• Burchfiel JL, Duffy FH. 1982. Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav Toxicol Teratol. 4:767–778.
   PubMedGoogle Scholar
• Burns RG, Islam K, Chapman R. 1984. The multiple phosphorylation of the microtubule-associated protein MAP-2 controls the MAP2: tubulin interaction. Eur J Biochem. 141:609–615.
   PubMedGoogle Scholar
• Bus J, Maurissen J, Marable B, Mattsson J. 2003. Association between organophosphate exposure and hyperactivity? Nat Genet. 34:235.
   PubMed Web of Science ®Google Scholar
• Cannard K. 2006. The acute treatment of nerve agent exposure. J Neurol Sci. 249:86–94.
   PubMed Web of Science ®Google Scholar
• Carey JL, Dunn C, Gaspari RJ. 2013. Central respiratory failure during acute organophosphate poisoning. Respir Physiol Neurobiol. 189:403–410.
   PubMed Web of Science ®Google Scholar
• Carrington CD, Abou-Donia MB. 1985. Axoplasmic transport and turnaround of neurotoxic esterase in hen sciatic nerve. J Neurochem. 44:616–621.
   PubMed Web of Science ®Google Scholar
• Casale GP, Cohen SD, DiCapua RA. 1982. The effects of organophosphate-induced cholinergic stimulation on the antibody response to sheep erythrocytes in inbred mice. Toxicol Appl Pharmacol. 68:198–205.
   Web of Science ®Google Scholar
• Chanda S, Song J, Rezk P, Sabnekar P, Doctor BP, Sciuto AM, Nambiar MP. 2010. Gastrointestinal acetylcholinesterase activity following endotracheal microintillation inhalation exposure to sarin in guinea pigs. Chem Biol Interact. 187:309–311.
   PubMed Web of Science ®Google Scholar
• Chao LL, Kriger S, Buckley S, Ng P, Mueller SG. 2014. Effects of low-level sarin and cyclosarin exposure on hippocampal subfields in Gulf War Veterans. Neurotoxicology. 44:263–269.
   PubMed Web of Science ®Google Scholar
• Chao LL, Rothlind JC, Cardenas VA, Meyerhoff DJ, Weiner MW. 2010. Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on brain function and brain structure of US veterans. Neurotoxicology. 31:493–501.
   PubMed Web of Science ®Google Scholar
• Chebabo SR, Santos MD, Albuquerque EX. 1999. The organophosphate sarin, at low concentrations, inhibits the evoked release of GABA in rat hippocampal slices. Neurotoxicology. 20:871–882.
   PubMed Web of Science ®Google Scholar
• ChemIDplus Advanced. 2009. Sarin: toxicity. Retrieved June 15th, 2009, from: http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/Toxicity.jsp
   Google Scholar
• Chen JW, Wasterlain CG. 2006. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 5:246–256.
   PubMed Web of Science ®Google Scholar
• Chen Y. 2012. Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. Neurotoxicology. 33:391–400.
   PubMed Web of Science ®Google Scholar
• Coleman IW, Patton GE, Bannard RA. 1968. Cholinolytics in the treatment of anticholinesterase poisoning. V. The effectiveness of Parpanit with oximes in the treatment of organophosphorus poisoning. Can J Physiol Pharmacol. 46:109–117.
   PubMed Web of Science ®Google Scholar
• Collins JL, Peng X, Lee R, Witriol A, Pierre Z, Sciuto AM. 2013. Determination of LCt(50)s in anesthetized rats exposed to aerosolized nerve agents. Toxicol Mech Methods. 23:127–133.
   PubMed Web of Science ®Google Scholar
• Collombet J-M. 2011. Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects. Toxicol Appl Pharmacol. 255:229–241.
   PubMed Web of Science ®Google Scholar
• Colosio C, Tiramani M, Maroni M. 2003. Neurobehavioral effects of pesticides: state of the art. Neurotoxicology. 24:577–591.
   PubMed Web of Science ®Google Scholar
• Conn CA, Dokladny K, Ménache MG, Barr EB, Kozak W, Wachulec M, Rudolph K, Kluger MJ, Henderson RF. 2002. Effects of sarin on temperature and activity of rats as a model for Gulf War Syndrome neuroregulatory functions. Toxicol Appl Pharmacol. 184:77–81.
   PubMed Web of Science ®Google Scholar
• Costa LG, Tait L, de Laat R, Dao K, Giordano G, Pellacani C, Cole TB, Furlong CE. 2013. Modulation of paraoxonase 2 (PON2) in mouse brain by the polyphenol quercetin: a mechanism of neuroprotection? Neurochem Res. 38:1809–1818. doi: 10.1007/s11064-013-1085-1. Epub 2013 Jun 7.
   PubMed Web of Science ®Google Scholar
• Crowell JA, Parker RM, Bucci TJ, Dacre JC. 1989. Neuropathy target esterase in hens after sarin and soman. J Biochem Toxicol. 4:15–20.
   PubMedGoogle Scholar
• Damodaran TV, Abdel-Rhman A, Abou-Donia MB. 2000. Early differential induction of c-jun in the central nervous system of hens treated with diisopropyl phosphorofluoroidate (DFP). Neurochem Res. 25:1579–1586.
   PubMed Web of Science ®Google Scholar
• Damodaran TV, Abou-Donia MB. 2000. Alterations in levels of MRNAs coding for glial fibrillary acidic protein (GFAP) and vimention genes in the central nervous system of hens trates with diisopropyl phosphorofluoridate (DFP). Neurochem Res. 25:809–816.
   PubMed Web of Science ®Google Scholar
• Damodaran TV, Attia MKM, Abou-Donia MB. 2011. Early differential cell death and survival mechanisms initiate and contribute to the development of OPIDN: a study of molecular, cellular and anatomical parameters. Toxicol Appl Pharmacol. 256:348–359.
   PubMed Web of Science ®Google Scholar
• Damodaran TV, Bilska MA, Abdel-Rahman AA, Abou-Donia MB. 2002. Sarin causes early differential alteration and persistent overexpression in mRNAs coding for glial fibrillary acidic protein (GFAP) and vimentin genes in the central nervous system of rats. Neurochem Res. 27:407–415.
   PubMed Web of Science ®Google Scholar
• Damodaran TV, Greenfield ST, Patel AG, Dressman HK, Lin SK, Abou-Donia MB. 2006b. Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure. Neurochem Res. 31:367–381.
   PubMed Web of Science ®Google Scholar
• Damodaran TV, Gupta RP, Abou-Donia MB. 2009. DFP initiated early alterations of PKA/p-CREB pathway and differential persistence of B-Tubulin subtypes in the CNS of hens contributed to OPIDN. Toxicol Appl Pharmacol. 240:132–142.
   PubMed Web of Science ®Google Scholar
• Damodaran TV, Jones KH, Patel AG, Abou-Donia MB. 2003. Sarin (nerve agent GB)-induced differential expression of mRNA coding for acetylcholinesterase gene in the rat central nervous system. Biochem Pharmacol. 65:2041–2947.
   PubMed Web of Science ®Google Scholar
• Damodaran TV, Mecklai AA, Abou-Donia MB. 2002. Sarin causes altered time course of mRNA expression of alpha tubulin in the central nervous system of rats. Neurochem Res. 27:177–181.
   PubMed Web of Science ®Google Scholar
• Damodaran TV, Patel AG, Greenfield ST, Dressman HK, Lin SM, Abou-Donia MB. 2006a. Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure. Biochem Pharmacol. 71:497–520.
   PubMed Web of Science ®Google Scholar
• Davies DR, Holland P. 1972. Effect of oximes and atropine upon the development of delayed neurotoxic signs in chickens following poisoning by DFP and sarin. Biochem Pharmacol. 21:3145–3151.
   PubMed Web of Science ®Google Scholar
• Dawson RM. 1994. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol. 14:317–331.
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Albert JP, DeLucia PR. 1982. Ca2+/calmodulin kinase dependent filamentous polymerization of tubulin. Soc Neurosci. 12th Annual Meeting Abstract; Minneapolis, MN, 281.
   Google Scholar
• Denk JR. 1975. DTIC EB-TR-74087, Subject: effects of GB mammalian germ cells and reproductive parameters.
   Google Scholar
• Deshpande SS, Smith CD, Filbert MG. 1995. Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Arch Toxicol. 69:384–390.
   PubMed Web of Science ®Google Scholar
• Duffy FH, Burchfiel JL, Bartels PH, Gaon M, Sim VM. 1979. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol. 47:161–176.
   PubMed Web of Science ®Google Scholar
• Earl CJ, Thompson RHS. 1952. The inhibitory action of tri-ortho-cresyl phosphate on cholinesterases. Br J Pharmacol Chemother. 7:261–269.
   PubMed Web of Science ®Google Scholar
• Eichler J, Toker L, Silman I. 1991. Combined exposure to heat and sarin significantly inhibited AChE but caused no significant effect on plasma BChE. Effect of heat shock on acetylcholinesterase activity in chick muscle cultures. FEBS Lett. 293:16–20.
   PubMed Web of Science ®Google Scholar
• Emerick GL, DeOliveira GH, dos Santos AC, Ehrich M. 2012. Mechanisms for consideration for intervention in the development of organophosphorus-induced delayed neuropathy. Chem Biol Interact. 199:177–184.
   PubMed Web of Science ®Google Scholar
• Fleisher JH, Harris LW, Prudhomme C, Bursel J. 1963. Effects of ethyl p-nitrophenyl thionobenzene phosphonate (EPN) on the toxicity of isopropyl methyl phosphonofluoridate (GB). J Pharmacol Exp Ther. 139:390–396.
   PubMed Web of Science ®Google Scholar
• Goldstein BD, Fincher DR, Searle JR. 1987. Electrophysiological changes in the primary sensory neuron following subchronic soman and sarin: alterations in sensory receptor function. Toxicol Appl Pharmacol. 91:55–64.
   PubMed Web of Science ®Google Scholar
• Gordon JJ, Inns RH, Johnson MK, Leadbeater L, Maidment MP, Upshall DG, Cooper GH, Rickard RL. 1983. The delayed neuropathic effects of nerve agents and some other organophosphorus compounds. Arch Toxicol. 52:71–82.
   PubMed Web of Science ®Google Scholar
• Gordon JJ, Leadbeater L. 1977. The prophylactic use of l-methyl, 2-hydroxyiminomethylpyridinium methanesulfonate (P2S) in the treatment of organophosphate poisoning. Toxicol Appl Pharmacol. 40:109–114.
   PubMed Web of Science ®Google Scholar
• Görne-Tschelnokow U, Naumann D, Weise C, Hucho F. 1993. Secondary structure and temperature behaviour of acetylcholinesterase. Studies by Fourier-transform infrared spectroscopy. Eur J Biochem. 213:1235–1242.
   PubMedGoogle Scholar
• Grandjean P, Landrigan PJ. 2006. Developmental neurotoxicity of industrial chemicals. Lancet. 368:2167–2178.
   PubMed Web of Science ®Google Scholar
• Grauer E, Chapman S, Rabinovitz I, Raveh L, Weissman BA, Kadar T, Allon N. 2008. Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits. Toxicol Appl Pharmacol. 227:265–274.
   PubMed Web of Science ®Google Scholar
• Greenwood JA, Johnson GV. 1995. Localization and in situ phosphorylation state of nuclear tau. Exp Cell Res. 220:332–337.
   PubMed Web of Science ®Google Scholar
• Grob D, Harvey JC. 1958. Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). J Clin Invest. 37:350–368.
   PubMed Web of Science ®Google Scholar
• Gundavarapu S, Xhuang J, Barrett EG, Xu F, Russell RG, Sopori ML. 2014. A critical role of acute bronchoconstriction in the mortality associated with high-dose sarin inhalation: effects of epinephrine and oxygen therapies. Toxicol Appl Pharmacol. 274:200–208.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Abdel-Rahman A, Jensen KF, Abou-Donia MB. 2000a. Altered expression of neurofilament subunits in diisopropyl phosphorofluoridate-treated hen spinal cord and their prescience in axonal aggregates. Brain Res. 878:32–47.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Abdel-Rahman A, Wilmarth KW, Abou-Donia MB. 1997. Alteration in neurofilament axonal transport in the sciatic nerve of the diisopropyl phosphorofluoridate (DFP)-treated hens. Biochem Pharmacol. 53:1799–1806.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Abou-Donia MB. 1994. In vivo and in vitro effects of diisopropyl phosphorofluoridate (DFP) on the rate of hen brain tubulin polymerization. Neurochem Res. 19:435–444.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Abou-Donia MB. 1995a. Diisopropyl phosphorofluoridate (DFP) treatment alters calcium-activated proteinase activity and cytoskeletal proteins in the hen sciatic nerve. Brain Res. 677:162–166.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Abou-Donia MB. 1995b. Neurofilaments phosphorylation and [125I] calmodulin binding by Ca2+/calmodulin-dependent protein kinase in the brain subcellular fractions of diisopropyl phosphorofluoridate (DFP)-treated hens. Neurochem Res. 20:1095–1110.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Abou-Donia MB. 1999. Tau phosphorylation by diisopropyl phosphorofluoridate (DFP)-treated hen brain supernatant inhibits its binding with microtubules: role of Ca2+/calmodulin-dependent protein kinase II in tau phosphorylation. Arch Biochem Biophys. 365:268–278.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Abdel-Rahman AA, Jensen KF, Abou-Donia MB. 2000. Altered expression of neurofilament subunits in diisopropyl phosphorfluoridate (DFP)-treated hen spinal cord and their presence in axanal aggregations. Brain Res. 878:32–47.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Abou-Donia MB. 2001. Enhanced activity and level of protein kinase A in the spinal cord supernatant of diisopropyl phosphorofluoridate (DFP)-treated hen. Distribution of protein kinases and phosphatases in spinal cord subcellular fractions. Mol Cell Biochem. 220:15–23.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Bing G, Hong J-S, Abou-Donia MB. 1998. cDNA cloning and sequencing of Ca2+/calmodulin-dependent protein kinase IIalpha subunit and its mRNA expression in diisopropyl phosphorofluoridate (DFP)-treated hen central nervous system. Mol Cell Biochem. 181:29–39.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Damodaran TV, Abou-Donia MB. 2000b. c-fos mRNA induction in the central and peripheral nervous system of diisopropyl phosphorofluoridate (DFP)-treated hens. Neurochem Res. 25:327–334.
   PubMed Web of Science ®Google Scholar
• Gupta RP, Lin WW, Abou-Donia MB. 1999. Enhanced mRNA expression of neurofilament subunits in the brain and spinal cord of diisopropyl phosphorofluoridate-treated hens. Biochem Pharmacol. 57:1245–1251.
   PubMed Web of Science ®Google Scholar
• Harel M Sussman JL, Krejci E, Bon S, Chanal P, Massoulié J, Silman I. 1992. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis. Proc Natl Acad Sci USA. 89:10827–10831.
   PubMed Web of Science ®Google Scholar
• Heaton KJ, Palumbo CL, Proctor SP, Killiany RJ, Yurgelun-Todd DA, White RF. 2007. Quantitative magnetic resonance brain imaging in US army veterans of the 1991 Gulf War potentially exposed to sarin and cyclosarin. Neurotoxicology. 28:761–769.
   PubMed Web of Science ®Google Scholar
• Henderson RF, Barr EB, Blackwell WB, Clark CR, Conn CA, Kalra R, March TH, Sopori ML, Tesfaigzi Y, Ménache MG, Mash DC. 2002. Response of rats to low levels of sarin. Toxicol Appl Pharmacol. 184:67–76.
   PubMed Web of Science ®Google Scholar
• Himuro K, Murayama S, Nishiyama K, Shinoe T, Iwase H, Nagao M, et al. 1998. Distal sensory axonopathy after sarin intoxication. Neurology. 51:1195–1197.
   PubMed Web of Science ®Google Scholar
• Hisanaga S-L, Hirokawa N. 1990. Dephosphorylation-induced interactions of neurofilaments with microtubules. J Biol Chem. 265:21852–21858.
   PubMed Web of Science ®Google Scholar
• Holisaz MT, Rayegani SM, Hafezy R, Khedmat H, Motamedi MH. 2007. Screening for peripheral neuropathy in chemical warfare victims. Int J Rehabil Res. 30:71–74.
   PubMed Web of Science ®Google Scholar
• Hoshi M, Akiyama T, Shinohara Y, Miyata Y, Ogawara H, Nishida E, Sakai H. 1988. Protein kinase C catalyzed phosphorylation of the microtubule-binding domain of microtubule associated protein 2 inhibits its ability to induce tubulin polymerization. Eur J Biochem. 174:225–230.
   PubMedGoogle Scholar
• Houston GC, Papadakis NG, Carpenter TA, Hall LD, Mukherjee B, James MF, Huang CL. 2001. Mapping of brain activation in response to pharmacological agents using fMRI in the rat. Magn Reson Imaging. 19:905–919.
   PubMed Web of Science ®Google Scholar
• Hulet SW, McDonough JH, Shih TM. 2002. The dose–response effects of repeated subacute sarin exposure on guinea pigs. Pharmacol Biochem Behav. 72:835–845.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. 1995. Health consequences of service during the Persian Gulf War: initial findings and recommendations for immediate action. Washington (DC): National Academy Press.
   Google Scholar
• Jamal GA, Julu POO. 2002. Low level exposures to organophosphorus esters may cause neurotoxicity. Toxicology. 181:23–33.
   PubMed Web of Science ®Google Scholar
• Jamal GA. 1997. Neurological syndromes of organophosphorus compounds. Adverse Drug React Toxicol Rev. 16:133–170.
   PubMedGoogle Scholar
• Jensen KF, Lapadula DM, Anderson JK, Haykal-Coates N, Abou-Donia MB. 1992. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J Neurosci Res. 33:455–460.
   PubMed Web of Science ®Google Scholar
• Jiang W, Duysen EG, Hansen H, Shlyakhtenko L, Schopfer L, Lockridge O. 2010. Mice treated with chlorpyrifos or chlorpyrifos oxon have organophosphorylated tubulin in the brain and disrupted microtubule structures, suggesting a role for tubulin in neurotoxicity associated with exposure to organophosphorus agents. Toxicol Sci. 115:183–193.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu X, Li S, Zhang Y, Piao F, Sun X. 2014. Identification of differentially expressed proteins related to organophosphorous-induced delayed neuropathy in the brains of hens. J Appl Toxicol. 34:1352–1360.
   PubMed Web of Science ®Google Scholar
• Johnson MK. 1969. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Br Biochem J. 114:711–717.
   PubMed Web of Science ®Google Scholar
• Jones KH, Dechkovskaia AM, Herrick EA, Abdel-Rahman AA, Khan WA, Abou-Donia MB. 2000. Subchronic effects following a single sarin exposure on blood brain barrier permeability, acetylcholinesterase and actylcholine receptors in the central nervous system of rat: a dose response study. J Toxicol Environ Health. 61:101–113.
   Web of Science ®Google Scholar
• Kadar T, Shapira S, Cohen G, Sahar R, Alkalay D, Raveh L. 1995. Sarin-induced neuropathology in rats. Hum Exp Toxicol. 14:252–259.
   PubMed Web of Science ®Google Scholar
• Kalow W, Davis RO. 1958. The activity of various esterase inhibitors towards atypical human serum cholinestarese. Biochem Pharmacol. 1:183–192.
   Web of Science ®Google Scholar
• Kalra R, Singh SP, Razani-Boroujerdi S, Langley RJ, Blackwell WB, Henderson RF, Sopori ML. 2002. Subclinical doses of the nerve gas sarin impair T cell responses through the autonomic nervous system. Toxicol Appl Pharmacol. 184:82–87.
   PubMed Web of Science ®Google Scholar
• Karalliedde L, Wheeler H, Maclehose R, Murray V. 2000. Review article – possible immediate and long-term health effects following exposure to chemical warfare agents. Public Health. 114:238–248.
   PubMed Web of Science ®Google Scholar
• Karenberg A. 2006. Neurosciences and the Third Reich Introduction. J History Neurosci. 15:168–172.
   PubMed Web of Science ®Google Scholar
• Kassa J, Karasova JD, Sepsova V, Kunesova G, Caisberger F, Pohanka M, Bajgar J. 2011. The ability of combinations of oximes to increase the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice. Abstracts/Toxicol Lett. 205S:S128.
   Google Scholar
• Kassa J, Koupilová M, Vachek J. 2001. The influence of low-level sarin inhalation exposure on spatial memory in rats. Pharmacol Biochem Behav. 70:175–179.
   PubMed Web of Science ®Google Scholar
• Kassa J, Krocová Z, Sevelová L, Sheshko V, Kasalová I, Neubauerová V. 2003. Low-level sarin-induced alteration of immune system reaction in inbred BALB/c mice. Toxicology. 187:195–203.
   PubMed Web of Science ®Google Scholar
• Kassa J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol. 40:803–816.
   PubMed Web of Science ®Google Scholar
• Khan WA, Dechkovskaia AM, Herrick EA, Jones KH, Abou-Donia MB. 2000. Acute sarin exposure causes differential regulation of choline acetyltransferase, acetylcholinesterase, and acetylcholine receptors in the central nervous system of the rat. Toxicol Sci. 57:112–120.
   PubMed Web of Science ®Google Scholar
• Kuca K, Cabal J. 2005. Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin nerve agent. Toxicol Mech Methods. 15:247–252.
   PubMed Web of Science ®Google Scholar
• Kuca K, Cabal J, Jun D, Bajgar J, Hrabinova M. 2006a. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterases. J Enzyme Inhib Med Chem. 21:663–666.
   PubMed Web of Science ®Google Scholar
• Kuca K, Cabal J, Kassa J. 2005. In vitro reactivation of sarin-inhibited brain acetylcholinesterase from different species by various oximes. J Enzyme Inhib Med Chem. 20:227–232.
   PubMed Web of Science ®Google Scholar
• Kuca K, Juna D, Musilek K. 2006b. Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem. 6:269–277.
   PubMed Web of Science ®Google Scholar
• La Du BN, Bartels CF, Nogueira CP, Arpagaus M, Lockridge O. 1991. Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing. Cell Mol Neurobiol. 11:79–89.
   PubMed Web of Science ®Google Scholar
• LaBorde JB, Bates HK, Dacre JC, Young JF. 1996. Developmental toxicity of sarin in rats and rabbits. J Toxicol Environ Health A. 47:249–265.
   Web of Science ®Google Scholar
• Lallement G, Delamanche IS, Pernot-Marino I, Baubichon D, Denoyer M, Carperntier P, Blanchet G. 1993. Neuroprotective activity of glutamate-receptor antagonists against soman-induced hippocampal damage: quantification with an omega-3 site ligand. Brain Res. 618:227–237.
   PubMed Web of Science ®Google Scholar
• Lancaster MC. 1960. A note on the demyelination produced in hens by dialkylfluoridates. Br J Pharmacol Chemother. 15:279–281.
   PubMed Web of Science ®Google Scholar
• Langston JL, Adkins AL, Moran AV, Rockwood GA, DeFord MS. 2005. Effects of sarin on the operant behavior of guinea pigs. Neurotoxicol Teratol. 27:841–853.
   PubMed Web of Science ®Google Scholar
• Lapadula ES, Lapadula DM, Abou-Donia MB. 1991. Persistent alterations of calmodulin kinase II activity in chickens after an oral dose of tri-o-cresyl phosphate. Biochem Pharmacol. 42:171–180.
   PubMed Web of Science ®Google Scholar
• Lapadula ES, Lapadula DM, Abou-Donia MB. 1992. Biochemical changes in sciatic nerve of hens treated with tri-o-cresyl phosphate: increased phosphorylation of cytoskeletal proteins. Neurochem Int. 20:247–255.
   PubMed Web of Science ®Google Scholar
• Leikin JB, Thomas RG, Walter FG, Klein R, Meislin HW. 2002. A review of nerve agent exposure for the critical care physician. Crit Care Med. 30:2346–2354.
   PubMed Web of Science ®Google Scholar
• Li Q, Nagahara N, Takahashi H, Takeda K, Okumura K, Minami M. 2002. Organophosphorus pesticides markedly inhibit the activities of natural killer, cytotoxic T lymphocyte and lymphokine-activated killer: a proposed inhibiting mechanism via granzyme inhibition. Toxicology. 172:181–190.
   PubMed Web of Science ®Google Scholar
• Li WS, Lum KT, Chen-Goodspeed M, Sogorb MA, Raushel FM. 2001. Stereoselective detoxification of chiral sarin and soman analogues by phosphotriesterase. Bioorg Med Chem. 9:2083–2091.
   PubMed Web of Science ®Google Scholar
• Lipp JA. 1968. Cerebral electrical activity following soman administration. Arch Int Pharmacodyn Ther. 175:161–169.
   PubMedGoogle Scholar
• Lockridge O. 1990. Genetic variants of serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther. 47:35–60.
   PubMed Web of Science ®Google Scholar
• Loh Y, Swanberg MM, Ingram MV, Newmark J. 2010. Case report: long-term cognitive sequelae of sarin exposure. Neurotoxicology. 31:244–246.
   PubMed Web of Science ®Google Scholar
• Lohs K. 1960. On the toxicology and pharmacology of organic phosphoric acid esters. Dtsch Gesundheitsw. 15:2179–2183.
   PubMedGoogle Scholar
• LoPachin RM, Lapadula DM, Abou-Donia MB. 1988. Organophosphate intoxication alters distribution of elements in chicken peripheral axons. Society for Neuroscience 18th Annual Meeting; Toronto, Canada. Abstracts Proceedings Vol. 4:775.
   Google Scholar
• Louis G, Stoker T. 2015. Endocrine disruptors. In: Abou-Donia MB, editor. Mammalian toxicology. Chichester, UK: John Wiley & Sons, 289–308.
   Google Scholar
• Mach M, Grubbs RD, Price WA, Nagaoka M, Dubovický M, Lucot JB. 2008. Delayed behavioral and endocrine effects of sarin and stress exposure in mice. J Appl Toxicol. 28:132–139.
   PubMed Web of Science ®Google Scholar
• Masson J. 2011. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett. 206:5–13.
   PubMed Web of Science ®Google Scholar
• Masuda N, Takatsu M, Morinari H. 1995. Sarin poisoning in Tokyo subway. Lancet. 345:1446–1447.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Shih TM, Adams N. 1993. Forebrain areas sensitive to the convulsant effects of the anticholinesterase agent VX. Soc Neurosci Abstr. 19:1630.
   Google Scholar
• McDonough JH, Shih TM. 1993. Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev. 17:203–215.
   PubMed Web of Science ®Google Scholar
• McDonough JH Jr, Shih TM. 1995. A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs. Pharmacol Biochem Behav.51:249–253.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Shih TM. 1997. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev. 21:559–579.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Smith RF, Smith CD. 1986. Behavioral-correlates of soman-induced neuropathology: deficits in DRL acquisition. Neurobehav Toxicol Teratol. 8:179–187.
   PubMedGoogle Scholar
• McDonough JH. 2002. Performance impacts of nerve agents and their pharmacological countermeasures. Mil Psychol. 14:93–119.
   Web of Science ®Google Scholar
• Miyaki K, Nishiwaki Y, Maekawa K, Ogawa Y, Asukai N, Yoshimura K, Etoh N, Matsumoto Y, Kikuchi Y, Kumagai N, Omae K. 2005. Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack. J Occup Health. 47:299–304.
   PubMed Web of Science ®Google Scholar
• Moore DH. 1998. Long term health effects of low dose exposure to nerve agent. J Physiol Paris. 92:325–328.
   PubMed Web of Science ®Google Scholar
• Morita H, Yanagisawa N, Nakajima T, Shimizu M, Hirabayshi H, Okudera M, Nohara M, Midorikawa Mimura S. 1995. Sarin poisoning in Matsumoto, Japan. Lancet. 346:290–293.
   PubMed Web of Science ®Google Scholar
• Moser VC. 2007. Animal models of chronic pesticide neurotoxicity. Hum Exp Toxicol. 26:321–332.
   PubMed Web of Science ®Google Scholar
• Mumford H, Troyer JK. 2011. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs. Toxicol Lett. 206:29–34.
   PubMed Web of Science ®Google Scholar
• Munirathinam S, Rogers G, Bahr BA. 2002. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors elicits neuroprotection after trimethyltin exposure in hippocampus. Toxicol Appl Pharmacol. 185:111–118.
   PubMed Web of Science ®Google Scholar
• Munro N. 1994. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection. Environ Health Perspect. 102:18–38.
   PubMed Web of Science ®Google Scholar
• Murata K, et al. 1997. Asymptomatic sequelae to acute sarin poisoning in central and autonomic nervous system 6 months after the Tokyo subway attack. J Neurol. 601–606.
   PubMed Web of Science ®Google Scholar
• Myhrer T, Aas P. 2014. Choice of approaches in developing novel medical countermeasures for nerve agent poisoning. Neurotoxicology. 44:27–38.
   PubMed Web of Science ®Google Scholar
• Myhrer T, Enger S, Aas P. 2008. Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman. Neurochem Res. 33:348–354.
   PubMed Web of Science ®Google Scholar
• Myhrer T. 2010. Identification of neuronal target areas for nerve agents and specification of receptors for pharmacological treatment. Neurotoxicology. 31:629–638.
   PubMed Web of Science ®Google Scholar
• Nachon F, Brazzolotto X, Trovaslet M, Masson P. 2013. Progress in the development of enzyme-based nerve agent bioscavengers. Chem Biol Interact. 206:536–544.
   PubMed Web of Science ®Google Scholar
• Namba T, Nolte CT, Jackrel J, Grob D. 1971. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med. 50:475–492.
   PubMed Web of Science ®Google Scholar
• Naylor DE, Liu H, Wasterlain CG. 2005. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci. 25:7724–7733.
   PubMed Web of Science ®Google Scholar
• Newmark J. 2007. Nerve agents. Neurologist. 13:20–32.
   PubMed Web of Science ®Google Scholar
• Nishiwaki Y, Maekawa K, Ogawa Y, Asukai N, Minami M, Omae K. 2001. Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack. Environ Health Perspect. 109:1169–1173.
   PubMed Web of Science ®Google Scholar
• O’Callahan JP. 2003. Neurotoxic esterase: not so toxic? Nat Genet. 33:1–2.
   PubMed Web of Science ®Google Scholar
• O’Donnell JC, McDonough JH, Shih TM. 2011. In vivo microdialysis and electroencephalographic activity in freely moving guinea pigs exposed to organophosphorus nerve agents sarin and VX: analysis of acetylcholine and glutamate. Arch Toxicol. 85:1607–1616.
   PubMed Web of Science ®Google Scholar
• Ohtani T, et al. 2004. Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a five year follow up study. Psychiatr Clin Neurosci. 58:624–629.
   PubMed Web of Science ®Google Scholar
• Okumura T, Hisaoka T, Naito T, Isonuma H, Okumura S, Miura K, Maekawa H, Ishimatsu S, Takasu N, Suzuki K. 2005. Acute and chronic effects of sarin exposure from the Tokyo subway incident. Environ Toxicol Pharmacol. 19:447–450.
   PubMed Web of Science ®Google Scholar
• Okumura T, Takasu N, Ishimatsu S, Miyanoki S, Misuhashi A, Kumada K, Tanaka K, Hinohara S. 1996. Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med. 28:129–135.
   PubMed Web of Science ®Google Scholar
• O'Callaghan JP. 2003. Neurotoxic esterase: not so toxic? Nat Genet. 33:437–438.
   PubMed Web of Science ®Google Scholar
• O'Leary JF, Kunkel AM, Jones AH. 1961. Efficacy and limitations of oxime-atropine treatment of organophosphorus anticholinesterase poisoning. J Pharmacol Exp Ther. 132:50–57.
   PubMed Web of Science ®Google Scholar
• Opresko DM, Young RA, Watson AP, Faust RA, Talmage SS, Ross RA, Davidson KA, King J, Hauschild V. 2001. Chemical warfare agents: current status of oral reference doses. Rev Environ Contam Toxicol. 172:65–85.
   Web of Science ®Google Scholar
• Oswal DP, Garrett TL, Morris M, Lucot JB. 2013. Low-dose sarin exposure produces long term changes in brain neurochemistry of mice. Neurochem Res. 38:108–116.
   PubMed Web of Science ®Google Scholar
• Patton SE, Lapadula DM, Abou-Donia MB. 1986. Relationship of tri-O-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord proteins. J Pharmacol Exp Ther. 239:597–605.
   PubMed Web of Science ®Google Scholar
• Patton SE, Lapadula DM, O’Callaghan JP, Miller DB, Abou-Donia MB. 1985. Changes in vitro brain and spinal cord protein phosphorylation after a single oral administration of tri-o-cresyl phosphate to hens. J Neurochem. 45:1567–1577.
   PubMed Web of Science ®Google Scholar
• Patton SE, O’Callaghan JP, Miller DB, Abou-Donia MB. 1983. Effect of oral administration of tri-o-cresyl phosphate on in vitro phosphorylation of membrane and cytosolic proteins from chicken brain. J Neurochem. 41:897–901.
   PubMed Web of Science ®Google Scholar
• Pearce PC, Crofts HS, Muggleton NG, Ridout D, Scott EA. 1999. The effects of acutely administered low dose sarin on cognitive behaviour and the electroencephalogram in the common marmoset. J Psychopharmacol (Oxford). 13:128–135. 1999.
   PubMed Web of Science ®Google Scholar
• Peña-Philippides JC, Razani-Boroujerdi S, Singh SP, Langley RJ, Mishra NC, Henderson RF, Sopori ML. 2007. Long- and short-term changes in the neuroimmune-endocrine parameters following inhalation exposures of F344 rats to low-dose sarin. Toxicol Sci. 97:181–188.
   PubMed Web of Science ®Google Scholar
• Petras JM. 1981. Soman neurotoxicity. Fund Appl Toxicol. (2):242–249.
   Google Scholar
• Pitschmann V. 2014. Review Overall view of chemical and biochemical weapons. Toxins 6:1761–1784.
   PubMed Web of Science ®Google Scholar
• Pilkington A, Jamal GA, Gilham R, Hansen S, Buchanan D, Kidd M, Azis MA, Julu PA, Al-Rawas S, Ballantyne JP, et al. 1999. Epidemiological study of the relationships between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers. Phase 3; Clinical neurological, neurophysiological and neuropsychological study. Official Report to British HSE, DoH and MAFF. 1–205.
   Google Scholar
• Pilkington P. 1999. A qualitative study of life after stroke. J Neurosci Nurs. 31:336–347.
   PubMedGoogle Scholar
• Pohanka M, Románek J, Pikula J. 2012. Acute poisoning with sarin causes alteration in oxidative homeostasis and biochemical markers in Wistar rats. J Appl Biomed. 10:187–192.
   Web of Science ®Google Scholar
• Pope CN, Tanaka D, Padilla S. 1993. The role of neurotoxic esterase in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity. Chem Biol Interact. 87:395–406.
   PubMed Web of Science ®Google Scholar
• Proctor SP, Heaton KJ, Heeren T, White RF. 2006. Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology. 27:931–939.
   PubMed Web of Science ®Google Scholar
• Radić Z, Dale T, Kovarik Z, Berend S, Garcia E, Zhang L, Amitai G, Green C, Radić B, Duggan BM, et al. 2013. Catalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes. Biochem J. 450:231–242.
   PubMed Web of Science ®Google Scholar
• RamaRao G, Acharya JN, Bhattacharya BK. 2011. Changes of protein oxidation, calpain and cytoskeletal proteins (alpha tubulin and pNF-H) levels in rat brain after nerve agent poisoning. Toxicol Lett. 203:236.
   Web of Science ®Google Scholar
• RamaRao G, Bhattacharya BK. 2012. Multiple signal transduction pathways alterations during nerve agent toxicity. Toxicol Lett. 208: 16–22.
   PubMed Web of Science ®Google Scholar
• Rengstorff RH. 1985. Accidental exposure to sarin: vision effects. Arch Toxicol. 56:201–203.
   PubMed Web of Science ®Google Scholar
• Research Advisory Committee on Gulf War Veterans' Illnesses. 2008. Gulf War Illness and the Health of Gulf War Veterans: Scientific Findings and Recommendations.
   Google Scholar
• Rodier PM. 1995. Developing brain as a target of toxicity. Environ Health Perspect. 103(Suppl 6):73–76.
   PubMed Web of Science ®Google Scholar
• Rosman Y, Eisenkraft A, Milk N, Shiyovich A, Ophir N, Shrot S, Kreiss Y, Kassirer M. 2014. Lessons learned from the Syrian sarin attack: evaluation of a clinical syndrome through social media. Ann Intern Med. 160:644–648. doi: 10.7326/M13-2799.
   PubMed Web of Science ®Google Scholar
• Ruhl CM, Park SJ, Danisa O, Morgan RF, Papirmeister B, Sidell FR, Edlich RF, Anthony LS, Himel HN. 1994. A serious skin sulfur mustard burn from an artillery shell. J Emerg Med. 12:159–166.
   PubMedGoogle Scholar
• Salama M, El-Morsy D, El-Gamal M, Shabka O, Mohamed WM. 2014. Mitochondrial complex I inhibition as a possible mechanism of chlorpyrifos induced neurotoxicity. Ann Neurosci. 21:85–89.
   PubMedGoogle Scholar
• Sawyer TW, Mikler J, Tenn C, Bjarnason S, Frew R. 2012. Non-cholinergic intervention of sarin nerve agent poisoning. Toxicology. 294:85–93.
   PubMed Web of Science ®Google Scholar
• Saxena A, Sun W, Dabisch PA, Hulet SW, Hastings NB, Jakubowski EM, Mioduszewski RJ, Doctor BP. 2008. Efficacy of human serum butyrylcholinesterase against sarin vapor. Chem Biol Interact. 175:267–272.
   PubMed Web of Science ®Google Scholar
• Sellner J, Trinka E. 2012. Seizures and epilepsy in herpes simplex virus encephalitis; current concepts and further directions of pathogenesis and management. J Neurol. 259:2019–2030.
   PubMed Web of Science ®Google Scholar
• Shewale SV, Anstadt MP, Horenziak M, Izu B, Morgan EE, Lucot JB, Morris M. 2012. Sarin causes autonomic imbalance and cardiomyopathy: an important issue for military and civilian health. J Cardiovasc Pharmacol. 60:76–87.
   PubMed Web of Science ®Google Scholar
• Shih ML, McMonagle JD, Dolzine TW, Gresham VC. 1994. Metabolite pharmacokinetics of soman, sarin and GF in rats and biological monitoring of exposure to toxic organophosphorus agents. J Appl Toxicol. 14:195–199.
   PubMed Web of Science ®Google Scholar
• Shih TM, Duniho SM, McDonough JH. 2003. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol. 188:69–80.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Hulet SW, McDonough JH. 2006. The effects of repeated low-dose sarin exposure. Toxicol Appl Pharmacol. 215: 119–134.
   PubMed Web of Science ®Google Scholar
• Shrot S, Markel G, Dushnitsky T, Krivoy A. 2009. The possible use of oximes as antidotal therapy in organophosphate-induced brain damage. Neurotoxicology. 30: 167–173.
   PubMed Web of Science ®Google Scholar
• Sidell FR. 1974. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol. 7:1–17.
   PubMed Web of Science ®Google Scholar
• Sit RK, Radic Z, Gerardi V, Zhang L, Garcia E, Katalinic M, Amitai G, Kovarik Z, Fokin VV, Sharpless KB, Taylor P. 2011. New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem. 286:19422–19430.
   PubMed Web of Science ®Google Scholar
• Skovira JW, O'Donnell JC, Koplovitz I, Kan RK, McDonough JH, Shih TM. 2010. Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigs. Chem Biol Interact. 187:318–324.
   PubMed Web of Science ®Google Scholar
• Smith MI, Elvove E, Valer PJ, Frazier WH, Mallory GE. 1930. Pharmacological and chemical studies of the cause of so-called ginger paralysis. U.S. Public Health Rep. 45:1703–1716.
   PubMedGoogle Scholar
• Somani SM, Romano JA Jr. 2001. Chemical warfare agents: toxicity at low levels. Boca Raton (FL): CRC Press.
   Google Scholar
• Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. 1991. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science. 253:872–879.
   PubMed Web of Science ®Google Scholar
• Suwita E, Lapadula DM, Abou-Donia MB. 1986a. Calcium and calmodulin-enhanced in vitro phosphorylation of hen brain cold-stable microtubules and spinal cord neurofilament triplet proteins after a single dose of tri-o-cresyl phosphate. Proc Natl Acad Sci USA. 76:4350–4354.
   Google Scholar
• Suwita E, Lapadula DM, Abou-Donia MB. 1986b. Calcium and calmodulin stimulated in vitro phosphorylation of rooster brain tubulin and MAP-2 following a single oral dose of tri-o-cresyl phosphate. Brain Res. 374:199–203.
   PubMed Web of Science ®Google Scholar
• Suwita E, Abou-Donia MB. 1990. Pharmacokinetics and metabolism of a single neurotoxic oral dose of tri-o-cresyl phosphate in hens. Arch Toxicol. 64:237–241.
   PubMed Web of Science ®Google Scholar
• Suzuki SM, Stevens RC, Richter RJ, Cole TB, Park S, Otto TC, Cerasoli DM, Lenz DE, Furlong CE. 2010. Engineering human PON1 in an E. coli expression system. Adv Exp Med Biol. 660:37–45.
   PubMed Web of Science ®Google Scholar
• Tokuda Y, Kikuchi M, Takahashi O, Stein GH. 2006. Prehospital management of sarin nerve gas terrorism in urban settings: 10 years progress after the Tokyo subway sarin attack. Resuscitation. 68:193–202.
   PubMed Web of Science ®Google Scholar
• Tripathi HL, Dewey WL. 1989. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice. J Toxicol Environ Health. 26:437–446.
   PubMed Web of Science ®Google Scholar
• Turner SR, Chad JE, Price M, Timperley CM, Bird M, Green AC, Tattersall JE. 2011. Protection against nerve agent poisoning by a noncompetitive nicotinic antagonist. Toxicol Lett. 206:105–111.
   PubMed Web of Science ®Google Scholar
• Üzümcü A. 2014. The chemical weapons convention – disarmament, science and technology. Anal Bioanal Chem. 406:5071–5073.
   PubMed Web of Science ®Google Scholar
• Vale A, Marrs TC, Rice P. 2011. Chemical terrorism and nerve agents. Chem Terror. 44 (2):106–108.
   Google Scholar
• Valiyaveettil M, Alamneh Y, Rezk P, Perkins MW, Sciuto AM, Doctor BP, Nambiar MP. 2011. Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs. Toxicol Lett. 202:203–208.
   PubMed Web of Science ®Google Scholar
• Van Meter WG, Karczmar AG. 1968. Prophylactic and antidotal treatment of sarin poisoning with drugs given singly and in combination. Arch Int Pharmacodyn Ther. 172:62–72.
   PubMedGoogle Scholar
• Walker CH, Mackness MI. 1987. “A” esterases and their role in regulating the toxicity of organophosphates. Arch Toxicol. 60:30–33.
   PubMed Web of Science ®Google Scholar
• Wandosell F, Serrano L, Hernandez MA, Avila J. 1986. Phosphorylation of tubulin by a calmodulin-dependent protein kinase. J Biol Chem. 261:10332–10339.
   PubMed Web of Science ®Google Scholar
• Whalley CE, McGuire JM, Miller DB, Jakubowski EM, Mioduszewski RJ, Thomson SA, Lumley LA, McDonough JH, Shih TM. 2007. Kinetics of sarin (GB) following a single sublethal inhalation exposure in the guinea pig. Inhal Toxicol. 19:667.
   PubMed Web of Science ®Google Scholar
• White RF, Proctor SP, Heeren T, Wolfe J, Krengel M, Vasterling J, Lindem K, Heaton KJ, Sutker P, Ozonoff DM. 2001. Neuropsychological function in Gulf War Veterans: relationships to self-reported toxicant exposures. Am J Ind Med. 40:42–54.
   PubMed Web of Science ®Google Scholar
• WHO. 1990. Public health impact of pesticides used in agriculture. Geneva: World Health Organization.
   Google Scholar
• Wills JH. 1961. Anticholinergic compounds as an adjuncts to atropine in preventing lethality by sarin in the rabbit. J Med Pharm Chem. 3:353–359.
   PubMedGoogle Scholar
• Winrow CJ, Hemming ML, Allen DA, Quistad GB, Casida JE, Barlow C. 2003. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat Genet. 33:477–485.
   PubMed Web of Science ®Google Scholar
• Worek F, Aurbek N, Thiermann H. 2007. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. J Appl Toxicol. 27:582–588.
   PubMed Web of Science ®Google Scholar
• Xintaras C, Burg JR, Tanaka S, Lee ST, Johnson BI, Cottrill CA, Bender J. 1978. NIOSH health survey of velsicol pesticide workers. Occupational Exposure to Leptophos and other chemicals. Cincinnati, Ohio: NIOSH.
   Google Scholar
• Yamasue H, Kasai K, Yamada H, Aoki S, Iwanami A, Ohtani T, Masutani Y, Kato N, Ohtomo K. 2006. Voxel-based diffusion tensor analysis reveals aberrant anterior cingulum integrity in posttraumatic stress disorder due to terrorism. Psychiatry Res. 146:231–242.
   PubMed Web of Science ®Google Scholar
• Yanagisawa N, Morita H, Nakajima T. 2006. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci. 249:76–85.
   PubMed Web of Science ®Google Scholar
• Yao Y, Liu J, Zhan CG. 2012. Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations. Biochemistry. 51:8980–8992.
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Araki S, Murata K, Nishikitani M, Okumura T, Ishimatsu S, Takasu N. 1998a. Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning. J Physiol Paris. 92:317–323.
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Araki S, Murata K, Nishikitani M, Okumura T, Ishimatsu S, Takasu N, White RF. 1998b. Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to post traumatic stress disorder. Arch Environ Health. 53:249–256.
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Araki S, Murata K, Nishikitani M, Okumura T, Ishimatsu S, Takasu N. 1998c. A preliminary study on delayed vestibulo-cerebellar effects of Tokyo Subway Sarin Poisoning in relation to gender difference: frequency analysis of postural sway. J Occup Environ Med. 40:17–21.
   PubMed Web of Science ®Google Scholar
• Yokoyama K. 2007. Our recent experiences with sarin poisoning cases in Japan and pesticide users with references to some selected chemicals. Neurotoxicology. 28:364–373.
   PubMed Web of Science ®Google Scholar
• Zou CS, Kou RR, Gao Y, Xie KQ, Song FY. 2012. Changes in autophagy-related protein levels in nervous tissues of hens with tri-ortho-cresyl phosphate-induced delayed neuropathy. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 30:748–750.
   PubMedGoogle Scholar